NCT01463202View on ClinicalTrials.gov

Timing of Postpartum Depot Medroxyprogesterone Acetate Administration on Breastfeeding, Contraceptive Continuation, and Depression

PHASE4CompletedINTERVENTIONAL
Enrollment

184

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

February 13, 2017

Study Completion Date

October 16, 2017

Conditions
ContraceptionPostpartum DepressionLactation
Interventions
DRUG

Depot medroxyprogesterone acetate

Postpartum administration of DMPA (prior to hospital discharge)

DRUG

Depot medroxyprogesterone acetate

Delayed administration of DMPA (4-6 weeks postpartum)

Trial Locations (1)

15213

Center for Family Planning Research, Magee-Womens Hospital, Pittsburgh

All Listed Sponsors
collaborator

Society of Family Planning

OTHER

lead

Beatrice Chen

OTHER

NCT01463202 - Timing of Postpartum Depot Medroxyprogesterone Acetate Administration on Breastfeeding, Contraceptive Continuation, and Depression | Biotech Hunter | Biotech Hunter